← Back

Wire · opportunities

Rapid Whole-Genome Sequencing Is Leaving the Research Ward and Entering the PICU Protocol

Published

25 August 2026

Topic

opportunities

Sectors

Health

Geography

United States

Source

Read at clinicaltrialvanguard.com

Verified

Fusion42 · 25 August 2026 · Fusion42 review

Rapid whole-genome sequencing (rWGS) has transitioned from a research tool to a citywide clinical standard across multiple pediatric ICUs, delivering diagnoses in a mean of 3.4 days, challenging existing regulatory frameworks and clinical trial protocols in neonatal and pediatric rare disease drug development.

This Wire brief sits within Fusion42's coverage of Health.

◆ The Wire takeaway

You must update trial protocols immediately to reflect that hospitals like Seattle Children's treat rapid whole-genome sequencing results as routine diagnostics, not investigational data. Your eligibility criteria and timelines are obsolete, risking enrolment delays and compromised randomization.

Coverage

1 source · 25 Aug 2026

Related on Wire

Topics

Healthrapid-wgsclinical-trialsrare-diseasepediatricsregulatory-shift